Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | PPARA | Q07869 | 10/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 8/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11512996 | 0.82 | CYP3A4 (0.54) | CYP3A4MEN1KMT2AADORA3CHRM1 | |
| SCHEMBL10834165 | 0.82 | ATM (0.41) | MEN1KMT2ACYP1A2CYP2C19MAPT | |
| SCHEMBL10460335 | 0.81 | CYP3A4 (0.56) | CYP3A4MEN1KMT2AADORA3CHRM1 | |
| SCHEMBL10001177 | 0.81 | CYP1A2 (0.53) | CYP3A4MEN1KMT2AADORA3CHRM1 | |
| SCHEMBL11512566 | 0.81 | CYP3A4 (0.52) | CYP3A4MEN1KMT2AADORA3CHRM1 | |
| SCHEMBL11216882 | 0.80 | CYP1A2 (0.54) | PPARACYP1A2CYP2C19MAPTPPARG | |
| SCHEMBL8496952 | 0.79 | CYP3A4 (0.51) | CYP3A4MEN1KMT2AADORA3CHRM1 | |
| SCHEMBL28032996 | 0.78 | PPARG (0.54) | PPARAPPARG | |
| SCHEMBL11806845 | 0.77 | PPARA (0.50) | CYP3A4MEN1KMT2AADORA3CHRM1 | |
| SCHEMBL11854999 | 0.77 | CYP3A4 (0.52) | CYP3A4MEN1KMT2AADORA3CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114890951-A | Synthesis method of Ganbaosu | 山东汉峰新材料科技有限公司 | 2022-08-12 | — | — | CN | disclosed |
| US-20050107454-A1 | Process for the purification of climbazole | SYMRISE GMBH & CO. KG. | 2005-05-19 | — | — | US | disclosed |
| EP-1531152-A1 | Process for purification of climbazol | Symrise GmbH & Co. KG (DE) | 2005-05-18 | — | — | EP | disclosed |
| EP-0112292-B1 | PLANT-GROWTH REGULATING AND MICROBICIDAL AGENTS | CIBA-GEIGY AG (CH) | 1987-07-29 | — | — | EP | disclosed |
| US-4610716-A | PLANT GROWTH REGULATORS, FUNGICIDES | CIBA-GEIGY CORPORATION (US) | 1986-09-09 | — | — | US | disclosed |
| EP-0112292-A1 | Plant-growth regulating and microbicidal agents | CIBA-GEIGY AG (CH) | 1984-06-27 | — | — | EP | disclosed |
| EP-0046532-B1 | 3,3-DIMETHYL-1-FLUORO-1-PHENOXY-2-BUTANONES(OLS), PROCESS FOR THEIR PREPARATION AND THEIR USE | BAYER AG (DE) | 1983-09-14 | — | — | EP | disclosed |
| EP-0046532-A1 | 3,3-Dimethyl-1-fluoro-1-phenoxy-2-butanones(ols), process for their preparation and their use | BAYER AG (DE) | 1982-03-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050107454-A1 | Process for the purification of climbazole | CA7, CYP3A7, CYP51A1 | CYP3A4 39/4885MEN1 3081/4885KMT2A 3751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.